Company profile

Amicus AG

Amicus is designed to fully replace multinationals’ subsidiaries in those countries that the multinational chooses not to enter, or to exit.Amicus is dedicated to service of research-based pharmaceutical and healthcare companies who choose to enter the Balkans and the Baltics in partnership, and not entirely with their own subsidiaries. The company is staffed by a unique group of skilled managers and medical professionals who are dedicated to bring modern medicines to the people of our two regions. We are a service-oriented, high quality and ethically-driven company.

More news about Amicus AG

21.05.2021 13:17

Swixx BioPharma secures close to €100 million to fuel its growth

Please login or
register to use the
awards follow feature
28.04.2017 14:14

HBM invests EUR 20 million in Amicus

Please login or
register to use the
awards follow feature
Amicus AG

Founded
2013

Kanton
ZG

Homepage

rss